World India's Serum Institute seeks approval to make Russia's Sputnik V vaccine On top of the AstraZeneca PLC and Novavax Inc shots it is already producing. Reuters Published June 3, 2021 Facebook Twitter Whatsapp Comments Follow us NEW DELHI: The Serum Institute of India has sought regulatory approval to make Russia's Sputnik V COVID-19 vaccine, local media reported on Thursday, on top of the AstraZeneca PLC and Novavax Inc shots it is already producing. AstraZeneca Sputnik V vaccine Comments Comments are closed. Markets Selling pressure persists as KSE-100 plunges record 3,790 points on profit-taking India's Serum Institute seeks approval to make Russia's Sputnik V vaccine PM Shehbaz leaves for Egypt for ‘Developing Eight’ countries summit Internet disruption: IT minister says national security top priority of government Aurangzeb optimistic about economic trajectory amid positive indicators Rupee remains largely stable against US dollar NA speaker says office open 24 hours, ‘ready to play role in govt, PTI talks’ Pakistan’s power generation increases in November as cost inches up Attock Cement’s parent company considering options including potential sale Gold price per tola gains Rs1,000 in Pakistan As bitcoin soars, luxury brands consider accepting crypto payments Interest rate cut to help stimulate economic growth: PM Read more stories
Comments
Comments are closed.